Viral Vector Contract Development Manufacturing Organizations Market, By Vector Type, By Workflow Stage, By Scale, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

Viral Vector Contract Development Manufacturing Organizations Market size was valued at US$ 1,123 Million in 2024, expanding at a CAGR of 18.5% from 2025 to 2032.

The Viral Vector Contract Development and Manufacturing Organizations (CDMO) Market focuses on outsourcing services for the production of viral vectors used in gene therapies, vaccines, and cell-based treatments. Over 30 gene therapy approvals globally by mid-2024 and an expanding pipeline of AAV, lentiviral, and adenoviral vector trials are fueling demand for specialized manufacturing. Rising investments from pharma and biotech firms are pushing CDMOs to scale up, with Thermo Fisher Scientific investing $650 million in 2023 to expand its cell and gene therapy network. However, high production costs, complex bioprocessing, and regulatory scrutiny over viral safety and consistency may restrain progress. Nonetheless, opportunities are emerging through strategic partnerships, platform standardization, and rising demand from regions lacking domestic vector production.

Viral Vector Contract Development Manufacturing Organizations Market- Market Dynamics

Expanding Gene Therapy Pipeline and Biotech Investments Accelerate Growth of Viral Vector CDMO Market

The rapid expansion of gene therapy pipelines and increased biotech investments are accelerating the growth of the viral vector CDMO market. As of 2024, over 2,000 gene therapy clinical trials are active globally, according to the U.S. FDA and Alliance for Regenerative Medicine. This surge has prompted major pharmaceutical players to outsource vector production to specialized CDMOs to meet scalability and compliance needs. In 2023, the U.S. Biomedical Advanced Research and Development Authority (BARDA) awarded funding to expand domestic viral vector manufacturing to reduce reliance on overseas supply. Companies like Catalent and Thermo Fisher Scientific have invested hundreds of millions to enhance viral vector infrastructure, addressing the rising demand for AAV and lentiviral vectors in oncology and rare disease therapies. These developments underscore a clear trend toward long-term CDMO partnerships and strategic capacity expansion across North America and Europe.

Viral Vector Contract Development Manufacturing Organizations Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 18.5% over the forecast period (2025-2032)

Based on Vector Type segmentation, Adeno-associated virus (AAV) was predicted to show maximum market share in the year 2024

Based on Workflow Stage segmentation, Upstream processing was the leading Workflow Stage in 2024

Based on Scale segmentation, the Clinical scale was the leading Scale in 2024

On the basis of region, North America was the leading revenue generator in 2024

Viral Vector Contract Development Manufacturing Organizations Market- Segmentation Analysis:

The Global Viral Vector Contract Development Manufacturing Organizations Market is segmented on the basis of Vector Type, Workflow Stage, Scale, Application, and Region.

The market is divided into six categories based on Vector Type: Adenovirus, Lentivirus, Adeno-associated Virus, Retrovirus, Herpes Simplex Virus, and Hybrid/Chimeric Vectors. Adeno-associated virus (AAV) leads due to its proven safety and efficiency in gene delivery, followed by lentivirus for stable gene integration. Adenovirus ranks third for vaccine development, while retrovirus, herpes simplex virus, and hybrid vectors are used in niche therapies.

The market is divided into two categories based on Workflow Stage: Upstream Processing (Cell culture (HEK293, Sf9), Transfection/infection protocols), and Downstream Processing (Filtration & Chromatography, Ultracentrifugation, Final Product Formulation). Upstream processing holds priority, with HEK293 cell culture and optimized transfection protocols widely used for scalable vector production. Downstream processing follows, where filtration and chromatography dominate purification, while ultracentrifugation and final formulation are essential for ensuring vector stability and clinical-grade quality.

Viral Vector Contract Development Manufacturing Organizations Market- Geographical Insights

North America holds a leading position in the viral vector CDMO market, supported by a robust biopharma ecosystem, government funding, and advanced infrastructure. In 2023, Thermo Fisher Scientific expanded its Maryland facility to enhance AAV vector production, while the U.S. FDA continued to accelerate approvals for gene therapies. Europe is also a key hub, with growing demand for contract manufacturing in Germany, the UK, and the Netherlands. In June 2024, Catalent collaborated with Oxford Biomedica to scale up viral vector manufacturing for European clients. Meanwhile, the Asia-Pacific region is emerging rapidly, led by China, Japan, and South Korea, where increasing government support for cell and gene therapy is prompting local CDMOs to boost capabilities. In 2024, Japan's AGC Biologics announced a strategic partnership with a local gene therapy company to establish viral vector production lines in Chiba, signaling regional capacity strengthening.

Viral Vector Contract Development Manufacturing Organizations Market- Competitive Landscape:

The viral vector CDMO market features strategic moves and capacity expansion among top players. Thermo Fisher Scientific leads the charge, acquiring Brammer Bio in 2019 and Novasep's Henogen division in January 2021 for approximatel €725 million (~$875 million), significantly enhancing its European viral vector footprint and complementing U.S. operations in Lexington, Cambridge, Plainville, and Alachua. Catalent-supporting over half of FDA-approved new drugs in the past decade and producing roughly 70 billion doses annually across 50+ facilities-was acquired by Novo Holdings for $16.5 billion in December 2024, reshaping contract manufacturing dynamics across drug, gene therapy, and injection delivery segments. Regional collaborations further enrich competition, such as Catalent's partnerships with Sarepta Therapeutics and multiple COVID-19 vaccine manufacturers. Together, these M&A and alliance strategies demonstrate intensifying differentiation through scale, global coverage, and therapeutic specialization.

Recent Developments:

In June 2025, ProBio opened a 128,000 sq ft GMP facility in Hopewell, New Jersey, to produce plasmid DNA and viral vectors. The site will begin AAV manufacturing by Q3 2025 and LVV services by Q1 2026.

In May 2024, Charles River Laboratories launched a viral vector tech transfer program, offering two frameworks-Fast Track for seamless transfers and Modular for customizable applications-to accelerate process handoffs to its Maryland Center of Excellence in as little as nine months.

In September 2024, Rentschler Biopharma launched a comprehensive lentiviral vector (LVV) manufacturing toolbox at its advanced therapies facility in Stevenage, UK, complementing its existing AAV services. This includes process development, cGMP manufacturing, and a royalty-free HEK293 cell line to accelerate ATMP production.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AGC Biologics
Aldevron
Batavia Biosciences
BioReliance (Merck KGaA)
Catalent
Charles River Laboratories
Cobra Biologics (Charles River)
FUJIFILM Diosynth Biotechnologies
Genezen
iBET
Kaneka Eurogentec
Lonza
Novasep
Oxford Biomedica
REGENXBIO (CDMO Services arm)
Thermo Fisher Scientific (Patheon)
Vigene Biosciences (Charles River)
VIVEbiotech
WuXi Advanced Therapies
Yposkesi
Others

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY VECTOR TYPE- MARKET ANALYSIS, 2019 - 2032

Adenovirus
Lentivirus
Adeno-associated Virus
Retrovirus
Herpes Simplex Virus
Hybrid/Chimeric Vectors

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY WORKFLOW STAGE- MARKET ANALYSIS, 2019 - 2032

Upstream Processing
Cell culture (HEK293, Sf9)
Transfection/infection protocols
Downstream Processing
Filtration & Chromatography
Ultracentrifugation
Final Product Formulation

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY SCALE- MARKET ANALYSIS, 2019 - 2032

Preclinical (R&D batches)
Clinical (Phase I-III)
Commercial (Market-ready supply)

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Gene Therapy
Cancer Immunotherapy
Infectious Disease Vaccines
Rare Disease Treatment

GLOBAL VIRAL VECTOR CONTRACT DEVELOPMENT MANUFACTURING ORGANIZATIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5543

1. Viral Vector Contract Development Manufacturing Organizations Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Vector Type
- 2.1.2. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Workflow Stage
- 2.1.3. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Scale
- 2.1.4. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Application
- 2.1.5. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Country
- 2.1.6. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Region
2.2. Competitive Insights

3. Viral Vector Contract Development Manufacturing Organizations Key Market Trends

3.1. Viral Vector Contract Development Manufacturing Organizations Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Viral Vector Contract Development Manufacturing Organizations Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Viral Vector Contract Development Manufacturing Organizations Market Opportunities
3.4. Viral Vector Contract Development Manufacturing Organizations Market Future Trends

4. Viral Vector Contract Development Manufacturing Organizations Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Viral Vector Contract Development Manufacturing Organizations Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Viral Vector Contract Development Manufacturing Organizations Market Landscape

6.1. Viral Vector Contract Development Manufacturing Organizations Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Viral Vector Contract Development Manufacturing Organizations Market - By Vector Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Vector Type, 2024 & 2032 (%)
- 7.1.2. Adenovirus
- 7.1.3. Lentivirus
- 7.1.4. Adeno-associated Virus
- 7.1.5. Retrovirus
- 7.1.6. Herpes Simplex Virus
- 7.1.7. Hybrid/Chimeric Vectors

8. Viral Vector Contract Development Manufacturing Organizations Market - By Workflow Stage

8.1. Overview
- 8.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
- 8.1.2. Upstream Processing
  - 8.1.2.1. Cell culture (HEK293, Sf9)
  - 8.1.2.2. Transfection/infection protocols
- 8.1.3. Downstream Processing
  - 8.1.3.1. Filtration & Chromatography
  - 8.1.3.2. Ultracentrifugation
  - 8.1.3.3. Final Product Formulation

9. Viral Vector Contract Development Manufacturing Organizations Market - By Scale

9.1. Overview
- 9.1.1. Segment Share Analysis, By Scale, 2024 & 2032 (%)
- 9.1.2. Preclinical (R&D batches)
- 9.1.3. Clinical (Phase I-III)
- 9.1.4. Commercial (Market-ready supply)

10. Viral Vector Contract Development Manufacturing Organizations Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Gene Therapy
- 10.1.3. Cancer Immunotherapy
- 10.1.4. Infectious Disease Vaccines
- 10.1.5. Rare Disease Treatment

11. Viral Vector Contract Development Manufacturing Organizations Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Viral Vector Contract Development Manufacturing Organizations Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. AGC Biologics
- 12.2.2. Aldevron
- 12.2.3. Batavia Biosciences
- 12.2.4. BioReliance (Merck KGaA)
- 12.2.5. Catalent
- 12.2.6. Charles River Laboratories
- 12.2.7. Cobra Biologics (Charles River)
- 12.2.8. FUJIFILM Diosynth Biotechnologies
- 12.2.9. Genezen
- 12.2.10. iBET
- 12.2.11. Kaneka Eurogentec
- 12.2.12. Lonza
- 12.2.13. Novasep
- 12.2.14. Oxford Biomedica
- 12.2.15. REGENXBIO (CDMO Services arm)
- 12.2.16. Thermo Fisher Scientific (Patheon)
- 12.2.17. Vigene Biosciences (Charles River)
- 12.2.18. VIVEbiotech
- 12.2.19. WuXi Advanced Therapies
- 12.2.20. Yposkesi
- 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us